Diebold Nixdorf, Incorporated financials

DBD CIK 0000028823

Source: EDGAR filings · Built 2026-05-29T02:27:39Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
EBITDA 369.50M 314.40M 151.40M -155.30M 208.00M 97.70M
Working Capital 415.30M 401.60M 732.90M 166.00M 137.90M 207.80M
Net Debt 745.50M 789.20M 815.70M 2.42B 2.06B 2.17B
Gross Margin 25.26% 24.53% 21.68% 21.88% 26.72% 26.52%
Operating Margin 6.36% 4.85% 5.67% -6.12% 3.51% 0.61%
Net Margin 2.49% -0.44% 0.82% -16.80% -2.02% -6.90%
Return on Equity (ROE) 8.60% -1.77% 1.26% 42.10% 9.32% 32.54%
Return on Assets (ROA) 2.45% -0.47% 0.32% -18.97% -2.25% -7.36%
Current Ratio 1.30× 1.32× 1.52× 1.10× 1.08× 1.13×
Debt-to-Equity 1.01× 1.17× 1.28× -1.97× -2.90× -3.02×
Effective Tax Rate 19.26% 135.94% 326.67% -34.02% -54.64% 0.37%
Cash Conversion Ratio 3.18× -9.04× 11.79× 0.67× -1.56× -0.07×
Accruals Ratio -0.05× -0.05× -0.03× -0.06× -0.06× -0.08×
SBC % of Revenue 0.32% 0.26% 0.01% 0.39% 0.35% 0.38%

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 26.73× 80.42×
EV / EBITDA 8.52× 7.65× 12.57×
P/S 0.63× 0.43× 0.67×
P/B 2.18× 1.74× 1.02×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenues 3.81B 3.75B 1.63B 3.46B 3.91B 3.90B
Cost of Goods and Services Sold 2.84B 2.83B 1.28B 2.70B 2.86B 2.87B
Gross Profit 961.20M 920.00M 353.00M 757.30M 1.04B 1.03B
Research and Development Expense 86.70M 93.60M 34.40M 120.70M 126.30M 133.40M
Selling, General and Administrative Expense 632.50M 643.60M 226.00M 741.60M 775.60M 858.60M
Operating Expenses 719.20M 737.90M 260.60M 969.00M 906.30M -1.01B
Operating Income (Loss) 242.00M 182.10M 92.40M -211.70M 137.10M 24.00M
Income Tax Expense (Benefit) 24.10M 64.30M -14.70M 149.20M 27.70M -1.00M
Net Income (Loss) Attributable to Parent 94.60M -16.50M 13.40M -581.40M -78.80M -269.10M
Earnings Per Share, Basic $2.57 $-0.44 $0.36 $-7.36 $-1.01
Weighted Average Number of Shares Outstanding, Basic 36.80M 37.60M 37.60M 79.00M 78.30M
Earnings Per Share, Diluted $2.54 $-0.44 $0.36 $-7.36 $-1.01 $-3.47
Weighted Average Number of Shares Outstanding, Diluted 37.20M 37.60M 37.60M 79.00M 78.30M 77.60M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 368.90M 296.20M 550.20M 307.40M
Assets, Current 1.79B 1.67B 2.15B 1.77B 1.89B 1.86B
Assets 3.85B 3.54B 4.16B 3.06B 3.51B 3.66B
Long-term Debt 938.50M 927.30M 1.25B 2.56B
Liabilities, Current 1.37B 1.27B 1.42B 1.60B 1.75B 1.65B
Long-term Debt, Excluding Current Maturities 938.50M 927.30M
Liabilities 2.75B 2.61B 3.08B 4.44B
Stockholders' Equity Attributable to Parent 1.10B 929.80M 1.06B -1.38B -845.10M -827.10M
Common Stock, Shares, Outstanding 35.38M 37.58M 37.57M 79.10M 78.35M 77.68M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 300.70M 149.20M 158.00M -387.90M 123.30M 18.00M
Net Cash Provided by (Used in) Investing Activities -97.60M -45.50M -20.10M -23.80M -49.20M -82.60M
Payments for Repurchase of Common Stock 130.70M 0 0 7.80M 7.70M 6.60M
Net Cash Provided by (Used in) Financing Activities -143.90M -366.50M -4.00M 349.80M -3.60M 16.90M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (DBD CIK 0000028823), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

IMRX

Immuneering Corporation

SAIC

Science Applications International Corporation

BH

BIGLARI HOLDINGS INC.